“…To address the delivery and accessibility of key intermediates or substrates, spatial optimization of isoprenoid synthesis pathways or key rate-limiting enzymes has been proposed to improve the biosynthesis of target compounds. Subcellular compartmentalization of metabolic pathways would allow higher local concentrations of enzymes, substrates, and intermediates, mitigating toxicity and bypassing the competing pathways, and the control of post-translational levels. , Subcellular compartmentalization strategies, a key advantage of eukaryotes over prokaryotes, have been reported to improve protein expression and have been successfully implemented to improve the production of high-value-added compounds in a variety of organelles, such as mitochondria, peroxisomes, , endoplasmic reticulum, and lipid droplets. , Recently, plasma membrane targeting strategies have been used to facilitate the production of valuable chemicals and to address intrapathway competitions . As well, some studies have improved the functional expression and substrate accessibility of membrane-anchored enzymes by relocalizing key rate-limiting enzyme genes to the plasma membrane. , However, the effect of the plasma membrane-anchoring strategy on the synthesis of monoterpene compounds has not been reported.…”